Massachusetts Life Sciences Center Announces 2019 Tax Incentive Program
The Massachusetts Life Sciences Center (MLSC) has announced a Life Sciences Tax Incentive Program for companies engaged in life sciences research and development, commercialization, and manufacturing in Massachusetts. Eligible companies must submit an application by February 8, 2019.
A quasi-public agency of Massachusetts, the Massachusetts Life Sciences Center is tasked with implementing the Massachusetts Life Sciences Act, a $1 billion initiative started in 2008. On June 15, 2018, new legislation was enacted to further invest up to $623 million in bond authorization and tax credits over five years in education, research and development, and workforce training.
The Massachusetts Life Sciences Tax Incentives Program is a set of ten different tax incentives, including the life sciences investment tax credit, FDA user fees credit, net operating loss extension, sales tax exemptions, jobs incentives, among others. The MLSC certifies companies and administers the tax incentives program.
Applicant life sciences companies must satisfy the following eligibility requirements:
- Registered to do business in Massachusetts.
- Employ at least 10 permanent FTEs (35 hours/week) as of December 31, 2018.
- Commit to hiring at least 10 net new jobs in calendar year 2019 and demonstrate an ability to retain these jobs through 2023.
- File a Massachusetts tax return either for a calendar year ending December 31, 2018, or for a fiscal year ending after December 31, 2018, but before October 31, 2019.
A Tax Incentive Program “Solicitation” provides further information on eligibility and the application process.
An interested life sciences company must submit an application with the MLSC on or before February 8, 2019 (12:00 p.m. EST).
Life sciences companies that are accepted by MLSC for the tax incentives program, in addition to meeting the continuing eligibility requirements, will be required to complete and file quarterly and annual reports. The annual report is also used to determine whether the company has met the specific targets set forth in its application. Failure to file required reports or satisfy targets is grounds for revocation of the company’s certification as a certified life sciences company. Upon decertification, any awarded tax incentives must be returned/repaid to the Massachusetts Department of Revenue.
Material discussed in this communication is meant to provide general information and should not be acted on without obtaining professional advice tailored to you or your company’s individual and specific needs. Any tax advice contained in this communication (including any attachments) is not intended or written to be used, and cannot be used by any person or entity, for the purpose of (i) avoiding penalties that may be imposed on any taxpayer or (ii) promoting, marketing or recommending to another party any transaction or matter addressed herein. This information is for general guidance only and is not a substitute for professional advice.
The information contained herein should not be construed as personalized investment advice. Investment in securities involves the risk of loss, and past performance is no guarantee of future results. There is no guarantee that the views and opinions expressed in this document will come to pass. Historical performance results for investment indexes and/or categories generally do not reflect the deduction of transaction and/or custodial charges or the deduction of an investment-management fee, the incurrence of which would have the effect of decreasing historical performance results. There can be no assurances that your portfolio will match or outperform any particular benchmark.
Information presented is believed to be factual and up-to-date; however, MFA makes no guarantee as to accuracy, completeness, suitability, or validity of any information within this communication and will not be liable for any errors, omissions, or delays in this information or any losses, injuries, or damages from its display or use. Any forward-looking statements are believed to be reasonable; however, MFA gives no assurance that such expectations will prove to be correct.